Towards personalized medicine mediated by in vitro virus-based interactome approaches

International Journal of Molecular Sciences

Volumn 15, Issue 4, 2014, Pages 6717-6724

  Ohashi, Hiroyuki ^a   Miyamoto Sato, Etsuko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cell free protein synthesis system; In vitro selection; In vitro virus; Protein protein interaction

Indexed keywords

ANTIBODY LABELING; COMPUTER MODEL; GENE SEQUENCE; GENOME ANALYSIS; GENOMICS; HUMAN; IN VITRO SELECTION; INTERACTOME; MASS SPECTROMETRY; MOLECULAR GENETICS; MRNA DISPLAY METHOD; MUTATION; NONHUMAN; PERSONALIZED MEDICINE; PROTEIN LIGAND INTERACTION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; RNA TRANSLATION; CELL FREE SYSTEM; METABOLISM; VIRUS;

MESSENGER RNA; PROTEIN;

CELL-FREE SYSTEM; GENOMICS; HUMANS; INDIVIDUALIZED MEDICINE; PROTEIN INTERACTION MAPS; PROTEINS; RNA, MESSENGER; VIRUSES;

EID: 84899133580     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15046717     Document Type: Review

References (32)

1. Hamdi, A.; Colas, P. Yeast two-hybrid methods and their applications in drug discovery. Trends Pharmacol. Sci. 2012, 33, 109-118
2. Dunham, W.H.; Mullin, M.; Gingras, A.C. Affinity-purification coupled to mass spectrometry: Basic principles and strategies. Proteomics 2012, 12, 1576-1590.
3. Deane, C.M.; Salwinski, L.; Xenarios, I.; Eisenberg, D. Protein interactions: Two methods for assessment of the reliability of high throughput observations. Mol. Cell. Proteomics 2002, 1, 349-356.
4. Edwards, A.M.; Kus, B.; Jansen, R.; Greenbaum, D.; Greenblatt, J.; Gerstein, M. Bridging structural biology and genomics: Assessing protein interaction data with known complexes. Trends Genet. 2002, 18, 529-536.
5. Miyamoto-Sato, E.; Nemoto, N.; Kobayashi, K.; Yanagawa, H. Specific bonding of puromycin to full-length protein at the C-terminus. Nucleic Acids Res. 2000, 28, 1176-1182.
6. Miyamoto-Sato, E.; Takashima, H.; Fuse, S.; Sue, K.; Ishizaka, M.; Tateyama, S.; Horisawa, K.; Sawasaki, T.; Endo, Y.; Yanagawa, H. Highly stable and efficient mRNA templates for mRNA-protein fusions and C-terminally labeled proteins. Nucleic Acids Res. 2003, 31, e78.
7. Nemoto, N.; Miyamoto-Sato, E.; Husimi, Y.; Yanagawa, H. In vitro virus: Bonding of mRNA bearing puromycin at the 3'-terminal end to the C-terminal end of its encoded protein on the ribosome in vitro. FEBS Lett. 1997, 414, 405-408.
8. Roberts, R.W.; Szostak, J.W. RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc. Natl. Acad. Sci. USA 1997, 94, 12297-12302.
9. Keefe, A.D.; Szostak, J.W. Functional proteins from a random-sequence library. Nature 2001, 410, 715-718.
10. Wilson, D.S.; Keefe, A.D.; Szostak, J.W. The use of mRNA display to select high-affinity protein-binding peptides. Proc. Natl. Acad. Sci. USA 2001, 98, 3750-3755.
11. Amstutz, P.; Forrer, P.; Zahnd, C.; Pluckthun, A. In vitro display technologies: Novel developments and applications. Curr. Opin. Biotechnol. 2001, 12, 400-405.
12. Miyamoto-Sato, E.; Fujimori, S.; Ishizaka, M.; Hirai, N.; Masuoka, K.; Saito, R.; Ozawa, Y.; Hino, K.; Washio, T.; Tomita, M., et al. A comprehensive resource of interacting protein regions for refining human transcription factor networks. PLoS One 2010, 5, e9289.
13. Nemoto, N.; Miyamoto-Sato, E.; Yanagawa, H. Fluorescence labeling of the C-terminus of proteins with a puromycin analogue in cell-free translation systems. FEBS Lett. 1999, 462, 43-46.
14. Doi, N.; Takashima, H.; Kinjo, M.; Sakata, K.; Kawahashi, Y.; Oishi, Y.; Oyama, R.; Miyamoto-Sato, E.; Sawasaki, T.; Endo, Y., et al. Novel fluorescence labeling and high-throughput assay technologies for in vitro analysis of protein interactions. Genome Res. 2002, 12, 487-492.
15. Tai, M.S.; Mudgett-Hunter, M.; Levinson, D.; Wu, G.M.; Haber, E.; Oppermann, H.; Huston, J.S. A bifunctional fusion protein containing Fc-binding fragment B of staphylococcal protein A amino terminal to antidigoxin single-chain Fv. Biochemistry 1990, 29, 8024-8030.
16. Legrain, P.; Selig, L. Genome-wide protein interaction maps using two-hybrid systems. FEBS Lett. 2000, 480, 32-36.
17. Rain, J.C.; Selig, L.; de Reuse, H.; Battaglia, V.; Reverdy, C.; Simon, S.; Lenzen, G.; Petel, F.; Wojcik, J.; Schachter V, et al. The protein-protein interaction map of Helicobacter pylori. Nature 2001, 409, 211-215.
18. Zhou, X.; Ren, L.; Meng, Q.; Li, Y.; Yu, Y.; Yu, J. The next-generation sequencing technology and application. Protein Cell 2010, 1, 520-536.
19. Chen, C.; Wan, H.; Zhou, Q. The next generation sequencing technology and its application in cancer research. Chin. J. Lung Cancer 2010, 13, 154-159. (in Chinese)
20. Woollard, P.M.; Mehta, N.A.; Vamathevan, J.J.; van Horn, S.; Bonde, B.K.; Dow, D.J. The application of next-generation sequencing technologies to drug discovery and development. Drug Discov. Today 2011, 16, 512-519.
21. Venkatesan, K.; Rual, J.F.; Vazquez, A.; Stelzl, U.; Lemmens, I.; Hirozane-Kishikawa, T.; Hao, T.; Zenkner, M.; Xin, X.; Goh K.I., et al. An empirical framework for binary interactome mapping. Nat. Methods 2009, 6, 83-90.
22. Yu, H.; Braun, P.; Yildirim, M.A.; Lemmens, I.; Venkatesan, K.; Sahalie, J.; Hirozane-Kishikawa, T.; Gebreab, F.; Li, N.; Simonis, N., et al. High-quality binary protein interaction map of the yeast interactome network. Science 2008, 322, 104-110.
23. Yu, H.; Tardivo, L.; Tam, S.; Weiner, E.; Gebreab, F.; Fan, C.; Svrzikapa, N.; Hirozane-Kishikawa, T.; Rietman, E.; Yang, X., et al. Next-generation sequencing to generate interactome datasets. Nat. Methods 2011, 8, 478-480.
24. Weimann, M.; Grossmann, A.; Woodsmith, J.; Ozkan, Z.; Birth, P.; Meierhofer, D.; Benlasfer, N.; Valovka, T.; Timmermann, B.; Wanker, E.E., et al. A Y2H-seq approach defines the human protein methyltransferase interactome. Nat. Methods 2013, 10, 339-342.
25. Fujimori, S.; Hirai, N.; Ohashi, H.; Masuoka, K.; Nishikimi, A.; Fukui, Y.; Washio, T.; Oshikubo, T.; Yamashita, T.; Miyamoto-Sato, E. Next-generation sequencing coupled with a cell-free display technology for high-throughput production of reliable interactome data. Sci. Rep. 2012, 2, 691.
26. Roberts, R.W. Totally in vitro protein selection using mRNA-protein fusions and ribosome display. Curr. Opin. Chem. Biol. 1999, 3, 268-273.
27. Wang, H.; Liu, R. Advantages of mRNA display selections over other selection techniques for investigation of protein-protein interactions. Expert Rev. Proteomics 2011, 8, 335-346.
28. Takahashi, T.T.; Austin, R.J.; Roberts, R.W. mRNA display: Ligand discovery, interaction analysis and beyond. Trends Biochem. Sci. 2003, 28, 159-165.
29. Vidal, M.; Cusick, M.E.; Barabasi, A.L. Interactome networks and human disease. Cell 2011, 144, 986-998.
30. Baker, M. Big biology: The 'omes puzzle. Nature 2013, 494, 416-419.
31. Dimitrakopoulou, K.; Dimitrakopoulos, G.N.; Sgarbas, K.N.; Bezerianos, A. Tamoxifen integromics and personalized medicine: Dynamic modular transformations underpinning response to tamoxifen in breast cancer treatment. OMICS 2014, 18, 15-33.
32. Sumida, T.; Yanagawa, H.; Doi, N. In vitro selection of fab fragments by mRNA display and gene-linking emulsion PCR. J. Nucleic Acids 2012, 2012, 371379.